Central Nervous System‐Active Medications and Risk of Hospital Readmission in Older Multimorbid Adults
Mirah J. Stuber(University of Bern), Carole E. Aubert, Denis O’Mahony(University College Cork), Wilma Knol(Utrecht University), Emma Jennings(University College Cork), Stéphanie Baggio(University of Bern), Huiberdina L. Koek(Utrecht University), Nicolas Rodondi(University of Bern), Olivia Dalleur(Cliniques Universitaires Saint-Luc), Anne Spinewine(CHU Dinant Godinne UCL Namur), Lara Brockhus(University of Bern)
Cited by 1
Related Papers
STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria
|Age and Ageing|2008|689
A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma
|New England Journal of Medicine|1982|281
Benefits and Risks of Using Smart Pumps to Reduce Medication Error Rates: A Systematic Review
|Drug Safety|2014|178
Medication-related clinical decision support alert overrides in inpatients
|Journal of the American Medical Informatics Association|2017|173